Scientists develop 'exercise pill'

May 01, 2007

A U.S. scientist has created an "exercise pill" that activates a gene that tells cells to burn fat, making mice resistant to high-fat diet weight gains.

Salk Institute scientist Ronald Evans and colleagues said by giving ordinary adult mice a synthetic designed to mimic fat, he has been able to chemically switch on PPAR-d, the master regulator gene that controls the ability of cells to burn fat. Even when the mice are not active, turning on the chemical switch activates the same fat-burning process that occurs during exercise.

The resulting shift in energy balance makes the mice resistant to weight gain even on a high fat diet.

Evans, who presented the study Monday in Washington during the Experimental Biology 2007 meeting, said his findings might lead to a new approach to the treatment and prevention of human metabolic syndrome.

Copyright 2007 by United Press International

Explore further: Evidence lacking for long-term opioid use in low back pain

add to favorites email to friend print save as pdf

Related Stories

Pets and anesthesia

Mar 21, 2014

Have you been avoiding getting your pet regular dental care? You're not alone. Most pet owners understand that in animals—just as in people—good oral health is conducive to overall well-being, says Gillian Fraser, V00, ...

Conversion from bad fat to good fat

Apr 28, 2013

Scientists from ETH Zurich in Switzerland have shown for the first time that brown and white fat cells in a living organism can be converted from one cell type to the other. Their work, using mice as a model organism, provides ...

Cell biology: Flushing out fats

Dec 19, 2012

The Wip1 protein is important for survival, but mutations that inactivate it carry some surprising features. "A lack of Wip1 results in an excessive immune reaction to infectious organisms, in some cases ...

Recommended for you

Pyridoxine-doxylamine drug safety data lacking

20 hours ago

(Medical Xpress)—The most commonly prescribed drug for pregnant women suffering from morning sickness in their first trimester does not prevent birth defects even though drug safety data says it does, according to research ...

FDA approves new type 2 diabetes drug

Apr 15, 2014

(HealthDay)—Millions of Americans with type 2 diabetes have a new treatment option with the U.S. Food and Drug Administration's approval Tuesday of a once-weekly injectable drug, Tanzeum.

User comments : 0

More news stories

Down's chromosome cause genome-wide disruption

The extra copy of Chromosome 21 that causes Down's syndrome throws a spanner into the workings of all the other chromosomes as well, said a study published Wednesday that surprised its authors.

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

Sony's PlayStation 4 sales top seven million

Sony says it has sold seven million PlayStation 4 worldwide since its launch last year and admitted it can't make them fast enough, in a welcome change of fortune for the Japanese consumer electronics giant.